FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF Trials

FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF	Welcome, Profile Billing Logout

FSAEI HE " First Moscow State Medical University n.a. I.M. Sechenov" of the MoH of the RF

Welcome, Profile Billing Logout

2 Trials

4 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Moiseev, Sergey

NCT06333210: Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

Active, not recruiting

421

RoW

anti-TRBV9 monoclonal antibody infusions, BCD-180 infusions, Placebo infusions, Adalimumab subcutaneous injection, Placebo subcutaneous injection

Biocad

Axial Spondyloarthritis

12/24

02/28

NCT05432960: Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

Withdrawn

RoW

RPH-104, goflikicept, Arcerix, Placebo

R-Pharm International, LLC, Exacte Labs LLC, Federal State Budgetary Educational Institution for Higher Education FSPbSMU n. a. I.P. Pavlov of the Ministry of Health of the Russian Federation, Scientific Center EFiS LLC, Data Management 365

Adult-Onset Still's Disease, AOSD

08/25

ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Recruiting

2/3

240

Europe, Canada, Japan, US, RoW

EFG PH20 SC, PBO

argenx, argenx BV

Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

12/26

02/27

FAVORIT, NCT06880250: Efficacy and Safety of Enzyme Replacement Therapy in Patients with Fabry Disease

Not yet recruiting

N/A

100

NPO Petrovax

Fabry Disease

01/27